Evidence map›Paper›PMID 24496236›Full record

ArticleThe Journal of investigative dermatology2014

Altered MCM protein levels and autophagic flux in aged and systemic sclerosis dermal fibroblasts.

Verónica I Dumit, Victoria Küttner, Jakob Käppler, Sonsoles Piera-Velazquez, Sergio A Jimenez, Leena Bruckner-Tuderman, Jouni Uitto, Jörn Dengjel

Abstract read
In one paragraph

Article in The Journal of investigative dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Senescent Cells Accumulate in Systemic Sclerosis Skin.The Journal of investigative dermatology · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Upcoming treatments for morphea.Immunity, inflammation and disease · 2021
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Verónica I DumitFreiburg Institute for Advanced Studies (FRIAS), School of Life Science (LifeNet), University of Freiburg, Freiburg, Germany; Center for Biological Systems Analysis (ZBSA), University Medical Center Freiburg, Freiburg, Germany. Electronic address: veronica.dumit@frias.uni-freiburg.de.
Victoria KüttnerFreiburg Institute for Advanced Studies (FRIAS), School of Life Science (LifeNet), University of Freiburg, Freiburg, Germany; Center for Biological Systems Analysis (ZBSA), University Medical Center Freiburg, Freiburg, Germany; Department of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany.
Jakob KäpplerCenter for Biological Systems Analysis (ZBSA), University Medical Center Freiburg, Freiburg, Germany.
Sonsoles Piera-VelazquezDepartment of Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania, USA.
Sergio A JimenezDepartment of Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania, USA.
Leena Bruckner-TudermanFreiburg Institute for Advanced Studies (FRIAS), School of Life Science (LifeNet), University of Freiburg, Freiburg, Germany; Center for Biological Systems Analysis (ZBSA), University Medical Center Freiburg, Freiburg, Germany; Department of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany.
Jouni UittoFreiburg Institute for Advanced Studies (FRIAS), School of Life Science (LifeNet), University of Freiburg, Freiburg, Germany; Department of Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania, USA.
Jörn DengjelFreiburg Institute for Advanced Studies (FRIAS), School of Life Science (LifeNet), University of Freiburg, Freiburg, Germany; Center for Biological Systems Analysis (ZBSA), University Medical Center Freiburg, Freiburg, Germany; Department of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany. Electronic address: joern.dengjel@frias.uni-freiburg.de.
University Medical Center Freiburg · DEUniversity of Freiburg · DEJefferson College · US

Funding

Identification of Novel Markers for Systemic Sclerosis Employing ProteomicsR21AR059970 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI JIMENEZ, SERGIO A · 2010 to 2011
$375k
NIAMS NIH HHS R21 AR059970
6 · The paper itself

Abstract

Aging is a common risk factor of many disorders. With age, the level of insoluble extracellular matrix increases leading to increased stiffness of a number of tissues. Matrix accumulation can also be observed in fibrotic disorders, such as systemic sclerosis (SSc). Although the intrinsic aging process in skin is phenotypically distinct from SSc, here we demonstrate similar behavior of aged and SSc skin fibroblasts in culture. We have used quantitative proteomics to characterize the phenotype of dermal fibroblasts from healthy subjects of various ages and from patients with SSc. Our results demonstrate that proteins involved in DNA and RNA processing decrease with age and in SSc, whereas those involved in mitochondrial and other metabolic processes behave the opposite. Specifically, minichromosome maintenance (MCM) helicase proteins are less abundant with age and SSc, and they exhibit an altered subcellular distribution. We observed that lower levels of MCM7 correlate with reduced cell proliferation, lower autophagic capacity, and higher intracellular protein abundance phenotypes of aged and SSc cells. In addition, we show that SSc fibroblasts exhibit higher levels of senescence compared with their healthy counterparts, suggesting further similarities between the fibrotic disorder and the aging process. Hence, at the molecular level, SSc fibroblasts exhibit intrinsic characteristics of fibroblasts from aged skin.

Indexed as

AdolescentAdultAgedAutophagyCells, CulturedChild, PreschoolDermisFemaleFibroblastsHumansInfant, NewbornMaleMiddle AgedMinichromosome Maintenance Complex Component 7PhenotypeProteomicsMCM7 protein, humanMinichromosome Maintenance Complex Component 7RNA, Messenger

Identifiers

PMID24496236
PMCPMC4121389
OpenAlexW2083538530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.